HighGravityDataMicrochip Technology — May 7, 2026 release
Fiscal 2026 fourth-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000827054-26-000012
Showing in the filing
Capital expenditures
“approximately $100 million”
Period
FY2027
Measure
Company-defined measure
Source
Prose
All guidance in this release · 31
Net sales midpoint for FY2026
“$1.456 billion”
Net sales
“$1.442 billion to $1.469 billion”
Non-GAAP gross margin
“approximately 62.25% to 63.25%”
Gross Profit (Non-GAAP) for Q1 FY2027
“62.25% to 63.25%”
Non-GAAP operating expense
“approximately 28.75% to 29.25%”
Operating Income (Non-GAAP) for Q1 FY2027
“33.00% to 34.50%”
Non-GAAP operating profit
“33.00% to 34.50%”
Non-GAAP earnings per share
“approximately $0.67 to $0.71”
Diluted net income per common share (Non-GAAP) for Q1 FY2027
“$0.67 to $0.71”
Quarterly cash dividend on common stock for FY2026
“45.5 cents per share”
Quarterly cash dividend
“45.5 cents per share”
Quarterly cash dividend on Series A Mandator… for FY2026
“$18.750 per share (which represents $0.9375 per depositary share)”
Quarterly cash dividend on 7.50% Series A Ma…
“$18.750 per share”
Net Sales for Q1 FY2027
“$1.442 to $1.469 billion”
Gross Profit (GAAP) for Q1 FY2027
“61.40% to 62.40%”
Operating Expenses (GAAP) for Q1 FY2027
“40.20% to 40.60%”
Operating Expenses (Non-GAAP) for Q1 FY2027
“28.75% to 29.25%”
Operating Income (GAAP) for Q1 FY2027
“20.80% to 22.20%”
Other Expense, net (GAAP) for Q1 FY2027
“$49.2 to $49.8 million”
Other Expense, net (Non-GAAP) for Q1 FY2027
“$49.0 to $50.0 million”
Income Tax Provision (GAAP) for Q1 FY2027
“$67.6 to $89.9 million”
Income Tax Provision (Non-GAAP) for Q1 FY2027
“$42.6 to $45.8 million”
Net income (GAAP) for Q1 FY2027
“$182.8 to $186.8 million”
Dividends on Series A Preferred Stock (GAAP) for Q1 FY2027
“$(27.8) million”
Net income attributable to common stockholde… for Q1 FY2027
“$155.0 to $159.0 million”
Net income attributable to common stockholde… for Q1 FY2027
“$383.4 to $411.9 million”
Diluted Common Shares Outstanding (GAAP) for Q1 FY2027
“Approximately 549.7 to 550.4 million shares”
Diluted Common Shares Outstanding (Non-GAAP) for Q1 FY2027
“Approximately 572.4 to 573.4 million shares”
Diluted net income per common share (GAAP) for Q1 FY2027
“$0.28 to $0.29”
Capital expenditures for FY2026
“approximately $20 million”
Capital expenditures for FY2027
“approximately $100 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
(5) Our GAAP guidance excludes the impact of any potential gains or charges related to our ongoing evaluation of restructuring activities including the sale of our Fab 2 wafer fabrication facility. Capital expenditures for the quarter ending June 30, 2026 are expected to be approximately $20 million. Capital expenditures for all of fiscal 2027 are expected to be approximately $100 million. Consistent with the slow macroeconomic environment in fiscal 2025, we have paused most of our factory expansion actions and reduced our planned capital investments through fiscal 2027. However, we are adding capital equipment to selectively expand our production capacity and add research and development equipment. Under the GAAP revenue recognition standard, we are required to recognize revenue when control of the product changes from us to a customer or distributor. We focus our sales and marketing efforts on creating demand for our products in the end markets we serve and not on moving inventory into our distribution network. We also manage our manufacturing and supply chain operations, including our distributor relationships, towards the goal of having our products available at the time and location the end customer desires. - - more - - Microchip Technology Reports Fourth Quarter and Fiscal 2026 Financial Results Page 6 Use of Non-GAAP Financial Measures: Our non-GAAP adjustments, where applicable, include the effect of share-based compensation, restructuring charges, cybersecurity incident expenses, expenses related to our acquisition activities (including intangible asset a
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.